peptide therapy

Hong Kong, China, August 10, 2026 Ascletis Pharma Inc. has announced the initiation of two Phase I clinical studies...

LONDON and SAN FRANCISCO, July 30, 2026 Verdiva Bio announced that the first patient has been dosed in a...

TURIN, Italy | June 19, 2026 Kither Biotech has announced the successful completion of its first-in-human Phase 1 clinical...

ENCINITAS, Calif., May 11, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies targeting cardiovascular and metabolic aging,...

Paris, France – October 16, 2025 – The U.S. Food and Drug Administration (FDA) has granted Fast Track designation...